pindolol has been researched along with celiprolol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Balasubramaniam, S; Chang, S; Hickie, JB; Simons, LA | 1 |
| Chi, LG; Frye, JW; Kitzen, JM; Lucchesi, BR; Lynch, JJ; Uprichard, AC | 1 |
| Imai, S; Ishibashi, T; Jin, H; Mitomi, A; Nakazawa, M; Ohta, H; Tatebe, S | 1 |
| Barrett, DA; Molinoff, PB; Neve, KA | 1 |
| Molinoff, PB; Neve, KA | 1 |
| Borchard, U; Brinkmann, M; Brodde, OE; Daul, A; Schemuth, R; Wang, XL | 1 |
| Molinoff, PB; Reynolds, EE | 1 |
| Insel, PA; Jasper, JR; Michel, MC | 1 |
| Lefflerová, K; Widimský, J | 1 |
| Berlin, E; Gjöres, JE; Thulesius, O | 1 |
| Magometschnigg, D; Rameis, H | 1 |
| Böhm, M; Emslander, HP; Hauck, RW; Schulz, C | 1 |
| Doggrell, SA; Henderson, CJ | 1 |
| Hayakawa, H; Hirata, Y; Kakoki, M; Kikuchi, K; Nagano, T; Nagata, D; Nishimatsu, H; Omata, M; Suzuki, E; Suzuki, Y | 1 |
| Aly, F; Belal, F; El-Awady, M; Hefnawy, M; Sharaf El-Din, M | 1 |
2 review(s) available for pindolol and celiprolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Middle Aged; Pindolol; Propanolamines | 1988 |
1 trial(s) available for pindolol and celiprolol
| Article | Year |
|---|---|
[Therapeutic problems in hyperkinetic heart syndrome].
Topics: Adrenergic beta-Antagonists; Celiprolol; Clinical Trials as Topic; Female; Heart Rate; Humans; Male; Oxprenolol; Pindolol; Propanolamines; Tachycardia; Verapamil | 1984 |
15 other study(ies) available for pindolol and celiprolol
| Article | Year |
|---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Celiprolol; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Lipids; Lipoproteins; Male; Pindolol; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Triglycerides | 1990 |
Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Celiprolol; Death, Sudden; Dogs; Electrocardiography; Female; Heart Rate; Male; Pindolol; Propanolamines; Sympathomimetics; Tachycardia | 1989 |
Partial agonist activity of celiprolol as assessed in conscious unrestrained dogs in comparison with those of pindolol and labetalol.
Topics: Adrenergic alpha-Agonists; Animals; Celiprolol; Dogs; Dose-Response Relationship, Drug; Heart; Hemodynamics; Labetalol; Male; Pindolol; Propanolamines; Sympathetic Nervous System | 1989 |
Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Celiprolol; Cells, Cultured; Glioma; Guanosine Triphosphate; Iodine Radioisotopes; Isoproterenol; Pindolol; Propanolamines; Rats; Receptors, Adrenergic, beta | 1985 |
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Celiprolol; Cells, Cultured; Ephedrine; Heart; Humans; Leukocytes; Pindolol; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta; Terbutaline | 1986 |
Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Bisoprolol; Blood Pressure; Celiprolol; Cyclic AMP; Female; Heart Rate; Humans; Isoproterenol; Kinetics; Lymphocytes; Male; Middle Aged; Pindolol; Propanolamines; Receptors, Adrenergic, beta | 1986 |
Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists.
Topics: Adrenergic beta-Agonists; Animals; Binding Sites; Celiprolol; Cell Division; Cell Line; Isoproterenol; Kinetics; Lymphoma; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Time Factors | 1986 |
Molecular mechanism of beta-adrenergic receptor blockers with intrinsic sympathomimetic activity.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Celiprolol; Colforsin; Cyclic AMP; Drug Synergism; Isoproterenol; Lymphoma; Pindolol; Propanolamines; Propranolol; Sympathomimetics; Tumor Cells, Cultured | 1988 |
Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Celiprolol; Humans; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Pindolol; Propanolamines; Sympathomimetics; Vasodilator Agents | 1982 |
Pharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchi.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Bronchi; Celiprolol; Dose-Response Relationship, Drug; Female; Guanylyl Imidodiphosphate; Heart; Humans; Male; Middle Aged; Pindolol; Propranolol | 1994 |
The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Celiprolol; Heart Ventricles; Isoproterenol; Male; Myocardial Contraction; Pindolol; Propranolol; Rats; Rats, Wistar | 1998 |
Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Benzopyrans; Celiprolol; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethanolamines; Hypertension; In Vitro Techniques; Kidney; Male; Metergoline; Muscle, Smooth, Vascular; Nebivolol; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Pindolol; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Quinazolines; Rats; Rats, Wistar; Renal Circulation; Serotonin Antagonists; Vasoconstriction; Vasodilator Agents | 1999 |
Fluorometric determination of bopindolol and celiprolol in pharmaceutical preparations and biological fluids.
Topics: Celiprolol; Drug Compounding; Fluorometry; Humans; Limit of Detection; Linear Models; Pindolol; Solvents | 2012 |